Eli Lilly told UK health secretary that new drug had ‘potential to prevent Alzheimer’s’
The drugmaker Eli Lilly told the-then UK health secretary last year that its new Alzheimer’s drug could be a one-off preventive treatment course, despite limited data to back up these claims, freedom of information requests have revealed.
A new bombshell has been dropped in the scandal-plagued world of Alzheimer’s disease drug development. | Between the two ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
UK MHRA grants marketing approval to Lilly's Kisunla to treat mild cognitive impairment and mild dementia due to Alzheimer's disease: Indianapolis Thursday, October 24, 2024, 09:0 ...
Eli Lilly’s (LLY) Kisunla for Alzheimer’s, and Merck’s (MRK) Winrevair for pulmonary arterial hypertension. Viking Therapeutics stock ramped higher Thursday after the company outlined its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback